Cargando…
Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance
Hypoxia-induced cisplatin resistance is a major challenge during non-small cell lung cancer (NSCLC) treatment. Based on previous studies, we further explored the effect of eukaryotic initiation factor 5A2 (eIF5A2) in hypoxia-induced cisplatin resistance. In this study, we found that autophagy and ci...
Autores principales: | Xu, Guodong, Chen, Hang, Wu, Shibo, Chen, Jiabin, Zhang, Shufen, Shao, Guofeng, Sun, Lebo, Mu, Yinyu, Liu, Kaitai, Pan, Qiaoling, Li, Ni, An, Xiaoxia, Lin, Shuang, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356061/ https://www.ncbi.nlm.nih.gov/pubmed/35931669 http://dx.doi.org/10.1038/s41419-022-05033-y |
Ejemplares similares
-
MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2
por: Pan, Qiaoling, et al.
Publicado: (2018) -
Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021) -
Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021) -
Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2
por: Xu, Guodong, et al.
Publicado: (2014) -
Lysosome-related genes: A new prognostic marker for lung adenocarcinoma
por: Hu, Zeyang, et al.
Publicado: (2023)